639 related articles for article (PubMed ID: 26976826)
1. Role of memory T cell subsets for adoptive immunotherapy.
Busch DH; Fräßle SP; Sommermeyer D; Buchholz VR; Riddell SR
Semin Immunol; 2016 Feb; 28(1):28-34. PubMed ID: 26976826
[TBL] [Abstract][Full Text] [Related]
2. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
3. To Remember or to Forget: The Role of Good and Bad Memories in Adoptive T Cell Therapy for Tumors.
Mondino A; Manzo T
Front Immunol; 2020; 11():1915. PubMed ID: 32973794
[TBL] [Abstract][Full Text] [Related]
4. The roles of stem cell memory T cells in hematological malignancies.
Xu L; Zhang Y; Luo G; Li Y
J Hematol Oncol; 2015 Oct; 8():113. PubMed ID: 26462561
[TBL] [Abstract][Full Text] [Related]
5. Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.
Quinn M; Turula H; Tandon M; Deslouches B; Moghbeli T; Snyder CM
J Immunol; 2015 Feb; 194(4):1726-1736. PubMed ID: 25595792
[TBL] [Abstract][Full Text] [Related]
6. Curtailed T-cell activation curbs effector differentiation and generates CD8
Zanon V; Pilipow K; Scamardella E; De Paoli F; De Simone G; Price DA; Martinez Usatorre A; Romero P; Mavilio D; Roberto A; Lugli E
Eur J Immunol; 2017 Sep; 47(9):1468-1476. PubMed ID: 28671275
[TBL] [Abstract][Full Text] [Related]
7. Generation and application of human induced-stem cell memory T cells for adoptive immunotherapy.
Kondo T; Imura Y; Chikuma S; Hibino S; Omata-Mise S; Ando M; Akanuma T; Iizuka M; Sakai R; Morita R; Yoshimura A
Cancer Sci; 2018 Jul; 109(7):2130-2140. PubMed ID: 29790621
[TBL] [Abstract][Full Text] [Related]
8. Memory T cells originate from adoptively transferred effectors and reconstituting host cells after sequential lymphodepletion and adoptive immunotherapy.
Wang LX; Kjaergaard J; Cohen PA; Shu S; Plautz GE
J Immunol; 2004 Mar; 172(6):3462-8. PubMed ID: 15004146
[TBL] [Abstract][Full Text] [Related]
9. T-memory cells against cancer: Remembering the enemy.
Sarkar I; Pati S; Dutta A; Basak U; Sa G
Cell Immunol; 2019 Apr; 338():27-31. PubMed ID: 30928016
[TBL] [Abstract][Full Text] [Related]
10. Principles for adoptive T cell therapy of human viral diseases.
Riddell SR; Greenberg PD
Annu Rev Immunol; 1995; 13():545-86. PubMed ID: 7612234
[TBL] [Abstract][Full Text] [Related]
11. Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.
Hinrichs CS; Borman ZA; Gattinoni L; Yu Z; Burns WR; Huang J; Klebanoff CA; Johnson LA; Kerkar SP; Yang S; Muranski P; Palmer DC; Scott CD; Morgan RA; Robbins PF; Rosenberg SA; Restifo NP
Blood; 2011 Jan; 117(3):808-14. PubMed ID: 20971955
[TBL] [Abstract][Full Text] [Related]
12. Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?
Klebanoff CA; Gattinoni L; Restifo NP
J Immunother; 2012; 35(9):651-60. PubMed ID: 23090074
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of Diverse Progenies of Memory T Cells from Naïve CD8
Zanon V; Lugli E
Methods Mol Biol; 2017; 1514():103-110. PubMed ID: 27787795
[TBL] [Abstract][Full Text] [Related]
14. Understanding memory CD8
Samji T; Khanna KM
Immunol Lett; 2017 May; 185():32-39. PubMed ID: 28274794
[TBL] [Abstract][Full Text] [Related]
15. The who's who of T-cell differentiation: human memory T-cell subsets.
Mahnke YD; Brodie TM; Sallusto F; Roederer M; Lugli E
Eur J Immunol; 2013 Nov; 43(11):2797-809. PubMed ID: 24258910
[TBL] [Abstract][Full Text] [Related]
16. Stem cell-like plasticity of naïve and distinct memory CD8+ T cell subsets.
Stemberger C; Neuenhahn M; Gebhardt FE; Schiemann M; Buchholz VR; Busch DH
Semin Immunol; 2009 Apr; 21(2):62-8. PubMed ID: 19269852
[TBL] [Abstract][Full Text] [Related]
17. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
18. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-specific T-cell Subsets in Human Peripheral Blood and After IFN-γ Immunomagnetic Selection.
Qian C; Wang Y; Cai H; Laroye C; De Carvalho Bittencourt M; Clement L; Stoltz JF; Decot V; Reppel L; Bensoussan D
J Immunother; 2016 Jan; 39(1):27-35. PubMed ID: 26641259
[TBL] [Abstract][Full Text] [Related]
20. Adoptive immunotherapy: good habits instilled at youth have long-term benefits.
Paulos CM; Suhoski MM; Plesa G; Jiang T; Basu S; Golovina TN; Jiang S; Aqui NA; Powell DJ; Levine BL; Carroll RG; Riley JL; June CH
Immunol Res; 2008; 42(1-3):182-96. PubMed ID: 18949448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
